GSL

AIMT failed breakout after first IPO base pattern.

NASDAQ:AIMT   AIMMUNE THERAPEUTICS INC
49 0 0
AIMT formed a classic cup-with-handle IPO             base, and eclipsed its buy point at $26.08 on a huge spike in volume on September 30. The breakout failed the very next day. Still basing. A downside break of $18.47 (the Aug 24 low) would set up a larger double-bottom base.
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out